The U.S. patent system is not in a good place today. Patents are worth substantially less than they were a decade ago, patents are much easier to challenge thanks to the high kill rate of the Patent Trial and Appeal Board (PTAB), and some of America’s most innovative industries face questions as to whether [...]
The Supreme Court’s most recent ruling on the issue, Alice Corp. v. CLS Bank has left the IP bar without a clear, reliable test to determine when exactly a software (or computer-implemented) claim is patentable versus being simply an abstract idea “free to all men and reserved exclusively to none.” This has left us [...]
Aylus Networks, Inc. (“Aylus”) owns the ’412 patent, which “provides systems and methods for implementing digital home networks having a control point located on a wide area network.” The patent teaches various network architectures for streaming and displaying media content using combinations of networked components. These networked components include: (1) a media server (“MS”); [...]
Coherus Biosciences stock rocketed to a month high wednesday after a U.S. BOARD tossed out a key patent protecting AbbVie's most important drug, arthritis medication Humira, thus clearing an obstacle from a similar treatment from coherus. recently U.S. PTAB, ruled against AbbViein a patent review and invalidated the dosing patent for Humira in rheumatoid [...]
Over the last month or so, the IP community has been abuzz with news and events that have culminated in interesting debates and discussions on the blog itself. Somewhere amidst all of the hustle, a simple two-page order of the Delhi High Court snagged national headlines for a few days last month. Let me [...]
The Federal Circuit vacated and remanded the Patent Trial and Appeal Board’s decision in an inter partes review proceeding that a patent owned by Rovalma S.A., which related to methods for making steels with certain thermal conductivities, was invalid for obviousness. In its Petition for inter partes review, Böhler-Edelstahl GmbH & Co. KG (“Böhler”) [...]
